India markets open in 38 minutes
  • BSE SENSEX

    48,080.67
    +374.87 (+0.79%)
     
  • Nifty 50

    14,406.15
    +109.75 (+0.77%)
     
  • Dow

    33,815.90
    -321.41 (-0.94%)
     
  • Nasdaq

    13,818.41
    -131.81 (-0.94%)
     
  • BTC-INR

    3,761,456.50
    -260,930.25 (-6.49%)
     
  • CMC Crypto 200

    1,134.39
    -108.66 (-8.74%)
     
  • Hang Seng

    29,039.04
    +283.70 (+0.99%)
     
  • Nikkei

    28,983.31
    -204.86 (-0.70%)
     
  • EUR/INR

    90.3159
    +0.0413 (+0.05%)
     
  • GBP/INR

    104.0278
    +0.0910 (+0.09%)
     
  • AED/INR

    20.4050
    0.0000 (0.00%)
     
  • INR/JPY

    1.4342
    -0.0004 (-0.03%)
     
  • SGD/INR

    56.5080
    -0.0240 (-0.04%)
     

Global Wound Care Biologics Market to Reach $2.9 Billion by 2027

ReportLinker
·26-min read

Abstract: - Global Wound Care Biologics Market to Reach $2. 9 Billion by 2027. - Amid the COVID-19 crisis, the global market for Wound Care Biologics estimated at US$1. 7 Billion in the year 2020, is projected to reach a revised size of US$2.

New York, April 08, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Wound Care Biologics Industry" - https://www.reportlinker.com/p06033318/?utm_source=GNW
9 Billion by 2027, growing at aCAGR of 8.5% over the period 2020-2027. Biologic Skin Substitutes, one of the segments analyzed in the report, is projected to record 9% CAGR and reach US$1.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Topical Agents segment is readjusted to a revised 7.8% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $446.5 Million, While China is Forecast to Grow at 12.9% CAGR
- The Wound Care Biologics market in the U.S. is estimated at US$446.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$676.8 Million by the year 2027 trailing a CAGR of 12.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 7.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR.

- Select Competitors (Total 42 Featured) -

  • Acell

  • Anika Therapeutics

  • Integra Lifesciences

  • Kerecis

  • Marine Polymer Technologies

  • Mimedx Group

  • Mölnlycke Health Care AB (Investor AB)

  • Organogenesis

  • Osiris Therapeutics

  • Smith & Nephew




Read the full report: https://www.reportlinker.com/p06033318/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Wound Care
Biologics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Wound Care Biologics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Wound Care Biologics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Biologic Skin
Substitutes by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Biologic Skin Substitutes by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Biologic Skin
Substitutes by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 7: World Current & Future Analysis for Topical Agents by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Topical Agents by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Topical Agents by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Ulcers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Ulcers by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Ulcers by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Surgical &
Traumatic Wounds by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Surgical & Traumatic Wounds
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Surgical & Traumatic
Wounds by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 16: World Current & Future Analysis for Burns by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 17: World Historic Review for Burns by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 18: World 15-Year Perspective for Burns by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Hospitals by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 20: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 21: World 15-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for ASCs by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 23: World Historic Review for ASCs by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for ASCs by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Burn Centers &
Wound Clinics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 26: World Historic Review for Burn Centers & Wound
Clinics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Burn Centers & Wound
Clinics by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

III. MARKET ANALYSIS

UNITED STATES
Table 28: USA Current & Future Analysis for Wound Care
Biologics by Product - Biologic Skin Substitutes and Topical
Agents - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 29: USA Historic Review for Wound Care Biologics by
Product - Biologic Skin Substitutes and Topical Agents Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 30: USA 15-Year Perspective for Wound Care Biologics by
Product - Percentage Breakdown of Value Sales for Biologic Skin
Substitutes and Topical Agents for the Years 2012, 2020 & 2027

Table 31: USA Current & Future Analysis for Wound Care
Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds
and Burns - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 32: USA Historic Review for Wound Care Biologics by Wound
Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 33: USA 15-Year Perspective for Wound Care Biologics by
Wound Type - Percentage Breakdown of Value Sales for Ulcers,
Surgical & Traumatic Wounds and Burns for the Years 2012, 2020 &
2027

Table 34: USA Current & Future Analysis for Wound Care
Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound
Clinics - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 35: USA Historic Review for Wound Care Biologics by
End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 36: USA 15-Year Perspective for Wound Care Biologics by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
ASCs and Burn Centers & Wound Clinics for the Years 2012, 2020 &
2027

CANADA
Table 37: Canada Current & Future Analysis for Wound Care
Biologics by Product - Biologic Skin Substitutes and Topical
Agents - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 38: Canada Historic Review for Wound Care Biologics by
Product - Biologic Skin Substitutes and Topical Agents Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 39: Canada 15-Year Perspective for Wound Care Biologics
by Product - Percentage Breakdown of Value Sales for Biologic
Skin Substitutes and Topical Agents for the Years 2012, 2020 &
2027

Table 40: Canada Current & Future Analysis for Wound Care
Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds
and Burns - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 41: Canada Historic Review for Wound Care Biologics by
Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 42: Canada 15-Year Perspective for Wound Care Biologics
by Wound Type - Percentage Breakdown of Value Sales for Ulcers,
Surgical & Traumatic Wounds and Burns for the Years 2012, 2020 &
2027

Table 43: Canada Current & Future Analysis for Wound Care
Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound
Clinics - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 44: Canada Historic Review for Wound Care Biologics by
End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 45: Canada 15-Year Perspective for Wound Care Biologics
by End-Use - Percentage Breakdown of Value Sales for Hospitals,
ASCs and Burn Centers & Wound Clinics for the Years 2012, 2020 &
2027

JAPAN
Table 46: Japan Current & Future Analysis for Wound Care
Biologics by Product - Biologic Skin Substitutes and Topical
Agents - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 47: Japan Historic Review for Wound Care Biologics by
Product - Biologic Skin Substitutes and Topical Agents Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 48: Japan 15-Year Perspective for Wound Care Biologics by
Product - Percentage Breakdown of Value Sales for Biologic Skin
Substitutes and Topical Agents for the Years 2012, 2020 & 2027

Table 49: Japan Current & Future Analysis for Wound Care
Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds
and Burns - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 50: Japan Historic Review for Wound Care Biologics by
Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 51: Japan 15-Year Perspective for Wound Care Biologics by
Wound Type - Percentage Breakdown of Value Sales for Ulcers,
Surgical & Traumatic Wounds and Burns for the Years 2012, 2020 &
2027

Table 52: Japan Current & Future Analysis for Wound Care
Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound
Clinics - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 53: Japan Historic Review for Wound Care Biologics by
End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 54: Japan 15-Year Perspective for Wound Care Biologics by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
ASCs and Burn Centers & Wound Clinics for the Years 2012, 2020 &
2027

CHINA
Table 55: China Current & Future Analysis for Wound Care
Biologics by Product - Biologic Skin Substitutes and Topical
Agents - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 56: China Historic Review for Wound Care Biologics by
Product - Biologic Skin Substitutes and Topical Agents Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 57: China 15-Year Perspective for Wound Care Biologics by
Product - Percentage Breakdown of Value Sales for Biologic Skin
Substitutes and Topical Agents for the Years 2012, 2020 & 2027

Table 58: China Current & Future Analysis for Wound Care
Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds
and Burns - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 59: China Historic Review for Wound Care Biologics by
Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 60: China 15-Year Perspective for Wound Care Biologics by
Wound Type - Percentage Breakdown of Value Sales for Ulcers,
Surgical & Traumatic Wounds and Burns for the Years 2012, 2020 &
2027

Table 61: China Current & Future Analysis for Wound Care
Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound
Clinics - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 62: China Historic Review for Wound Care Biologics by
End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 63: China 15-Year Perspective for Wound Care Biologics by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
ASCs and Burn Centers & Wound Clinics for the Years 2012, 2020 &
2027

EUROPE
Table 64: Europe Current & Future Analysis for Wound Care
Biologics by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 65: Europe Historic Review for Wound Care Biologics by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 66: Europe 15-Year Perspective for Wound Care Biologics
by Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 67: Europe Current & Future Analysis for Wound Care
Biologics by Product - Biologic Skin Substitutes and Topical
Agents - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 68: Europe Historic Review for Wound Care Biologics by
Product - Biologic Skin Substitutes and Topical Agents Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 69: Europe 15-Year Perspective for Wound Care Biologics
by Product - Percentage Breakdown of Value Sales for Biologic
Skin Substitutes and Topical Agents for the Years 2012, 2020 &
2027

Table 70: Europe Current & Future Analysis for Wound Care
Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds
and Burns - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 71: Europe Historic Review for Wound Care Biologics by
Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 72: Europe 15-Year Perspective for Wound Care Biologics
by Wound Type - Percentage Breakdown of Value Sales for Ulcers,
Surgical & Traumatic Wounds and Burns for the Years 2012, 2020 &
2027

Table 73: Europe Current & Future Analysis for Wound Care
Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound
Clinics - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 74: Europe Historic Review for Wound Care Biologics by
End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 75: Europe 15-Year Perspective for Wound Care Biologics
by End-Use - Percentage Breakdown of Value Sales for Hospitals,
ASCs and Burn Centers & Wound Clinics for the Years 2012, 2020 &
2027

FRANCE
Table 76: France Current & Future Analysis for Wound Care
Biologics by Product - Biologic Skin Substitutes and Topical
Agents - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 77: France Historic Review for Wound Care Biologics by
Product - Biologic Skin Substitutes and Topical Agents Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 78: France 15-Year Perspective for Wound Care Biologics
by Product - Percentage Breakdown of Value Sales for Biologic
Skin Substitutes and Topical Agents for the Years 2012, 2020 &
2027

Table 79: France Current & Future Analysis for Wound Care
Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds
and Burns - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 80: France Historic Review for Wound Care Biologics by
Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 81: France 15-Year Perspective for Wound Care Biologics
by Wound Type - Percentage Breakdown of Value Sales for Ulcers,
Surgical & Traumatic Wounds and Burns for the Years 2012, 2020 &
2027

Table 82: France Current & Future Analysis for Wound Care
Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound
Clinics - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 83: France Historic Review for Wound Care Biologics by
End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 84: France 15-Year Perspective for Wound Care Biologics
by End-Use - Percentage Breakdown of Value Sales for Hospitals,
ASCs and Burn Centers & Wound Clinics for the Years 2012, 2020 &
2027

GERMANY
Table 85: Germany Current & Future Analysis for Wound Care
Biologics by Product - Biologic Skin Substitutes and Topical
Agents - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 86: Germany Historic Review for Wound Care Biologics by
Product - Biologic Skin Substitutes and Topical Agents Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 87: Germany 15-Year Perspective for Wound Care Biologics
by Product - Percentage Breakdown of Value Sales for Biologic
Skin Substitutes and Topical Agents for the Years 2012, 2020 &
2027

Table 88: Germany Current & Future Analysis for Wound Care
Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds
and Burns - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 89: Germany Historic Review for Wound Care Biologics by
Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 90: Germany 15-Year Perspective for Wound Care Biologics
by Wound Type - Percentage Breakdown of Value Sales for Ulcers,
Surgical & Traumatic Wounds and Burns for the Years 2012, 2020 &
2027

Table 91: Germany Current & Future Analysis for Wound Care
Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound
Clinics - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 92: Germany Historic Review for Wound Care Biologics by
End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 93: Germany 15-Year Perspective for Wound Care Biologics
by End-Use - Percentage Breakdown of Value Sales for Hospitals,
ASCs and Burn Centers & Wound Clinics for the Years 2012, 2020 &
2027

ITALY
Table 94: Italy Current & Future Analysis for Wound Care
Biologics by Product - Biologic Skin Substitutes and Topical
Agents - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 95: Italy Historic Review for Wound Care Biologics by
Product - Biologic Skin Substitutes and Topical Agents Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 96: Italy 15-Year Perspective for Wound Care Biologics by
Product - Percentage Breakdown of Value Sales for Biologic Skin
Substitutes and Topical Agents for the Years 2012, 2020 & 2027

Table 97: Italy Current & Future Analysis for Wound Care
Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds
and Burns - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 98: Italy Historic Review for Wound Care Biologics by
Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 99: Italy 15-Year Perspective for Wound Care Biologics by
Wound Type - Percentage Breakdown of Value Sales for Ulcers,
Surgical & Traumatic Wounds and Burns for the Years 2012, 2020 &
2027

Table 100: Italy Current & Future Analysis for Wound Care
Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound
Clinics - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 101: Italy Historic Review for Wound Care Biologics by
End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 102: Italy 15-Year Perspective for Wound Care Biologics
by End-Use - Percentage Breakdown of Value Sales for Hospitals,
ASCs and Burn Centers & Wound Clinics for the Years 2012, 2020 &
2027

UNITED KINGDOM
Table 103: UK Current & Future Analysis for Wound Care
Biologics by Product - Biologic Skin Substitutes and Topical
Agents - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 104: UK Historic Review for Wound Care Biologics by
Product - Biologic Skin Substitutes and Topical Agents Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 105: UK 15-Year Perspective for Wound Care Biologics by
Product - Percentage Breakdown of Value Sales for Biologic Skin
Substitutes and Topical Agents for the Years 2012, 2020 & 2027

Table 106: UK Current & Future Analysis for Wound Care
Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds
and Burns - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 107: UK Historic Review for Wound Care Biologics by Wound
Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 108: UK 15-Year Perspective for Wound Care Biologics by
Wound Type - Percentage Breakdown of Value Sales for Ulcers,
Surgical & Traumatic Wounds and Burns for the Years 2012, 2020 &
2027

Table 109: UK Current & Future Analysis for Wound Care
Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound
Clinics - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 110: UK Historic Review for Wound Care Biologics by
End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 111: UK 15-Year Perspective for Wound Care Biologics by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
ASCs and Burn Centers & Wound Clinics for the Years 2012, 2020 &
2027

SPAIN
Table 112: Spain Current & Future Analysis for Wound Care
Biologics by Product - Biologic Skin Substitutes and Topical
Agents - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 113: Spain Historic Review for Wound Care Biologics by
Product - Biologic Skin Substitutes and Topical Agents Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 114: Spain 15-Year Perspective for Wound Care Biologics
by Product - Percentage Breakdown of Value Sales for Biologic
Skin Substitutes and Topical Agents for the Years 2012, 2020 &
2027

Table 115: Spain Current & Future Analysis for Wound Care
Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds
and Burns - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 116: Spain Historic Review for Wound Care Biologics by
Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 117: Spain 15-Year Perspective for Wound Care Biologics
by Wound Type - Percentage Breakdown of Value Sales for Ulcers,
Surgical & Traumatic Wounds and Burns for the Years 2012, 2020 &
2027

Table 118: Spain Current & Future Analysis for Wound Care
Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound
Clinics - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 119: Spain Historic Review for Wound Care Biologics by
End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 120: Spain 15-Year Perspective for Wound Care Biologics
by End-Use - Percentage Breakdown of Value Sales for Hospitals,
ASCs and Burn Centers & Wound Clinics for the Years 2012, 2020 &
2027

RUSSIA
Table 121: Russia Current & Future Analysis for Wound Care
Biologics by Product - Biologic Skin Substitutes and Topical
Agents - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 122: Russia Historic Review for Wound Care Biologics by
Product - Biologic Skin Substitutes and Topical Agents Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 123: Russia 15-Year Perspective for Wound Care Biologics
by Product - Percentage Breakdown of Value Sales for Biologic
Skin Substitutes and Topical Agents for the Years 2012, 2020 &
2027

Table 124: Russia Current & Future Analysis for Wound Care
Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds
and Burns - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 125: Russia Historic Review for Wound Care Biologics by
Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 126: Russia 15-Year Perspective for Wound Care Biologics
by Wound Type - Percentage Breakdown of Value Sales for Ulcers,
Surgical & Traumatic Wounds and Burns for the Years 2012, 2020 &
2027

Table 127: Russia Current & Future Analysis for Wound Care
Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound
Clinics - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 128: Russia Historic Review for Wound Care Biologics by
End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 129: Russia 15-Year Perspective for Wound Care Biologics
by End-Use - Percentage Breakdown of Value Sales for Hospitals,
ASCs and Burn Centers & Wound Clinics for the Years 2012, 2020 &
2027

REST OF EUROPE
Table 130: Rest of Europe Current & Future Analysis for Wound
Care Biologics by Product - Biologic Skin Substitutes and
Topical Agents - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 131: Rest of Europe Historic Review for Wound Care
Biologics by Product - Biologic Skin Substitutes and Topical
Agents Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 132: Rest of Europe 15-Year Perspective for Wound Care
Biologics by Product - Percentage Breakdown of Value Sales for
Biologic Skin Substitutes and Topical Agents for the Years
2012, 2020 & 2027

Table 133: Rest of Europe Current & Future Analysis for Wound
Care Biologics by Wound Type - Ulcers, Surgical & Traumatic
Wounds and Burns - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 134: Rest of Europe Historic Review for Wound Care
Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds
and Burns Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 135: Rest of Europe 15-Year Perspective for Wound Care
Biologics by Wound Type - Percentage Breakdown of Value Sales
for Ulcers, Surgical & Traumatic Wounds and Burns for the Years
2012, 2020 & 2027

Table 136: Rest of Europe Current & Future Analysis for Wound
Care Biologics by End-Use - Hospitals, ASCs and Burn Centers &
Wound Clinics - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 137: Rest of Europe Historic Review for Wound Care
Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound
Clinics Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 138: Rest of Europe 15-Year Perspective for Wound Care
Biologics by End-Use - Percentage Breakdown of Value Sales for
Hospitals, ASCs and Burn Centers & Wound Clinics for the Years
2012, 2020 & 2027

ASIA-PACIFIC
Table 139: Asia-Pacific Current & Future Analysis for Wound
Care Biologics by Geographic Region - Australia, India, South
Korea and Rest of Asia-Pacific Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06033318/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001